Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

Be aware that the dilution is modest (only partially exercised; they have the option to exercise the warrants in full...this reality has not happened yet).

In the event the warrants are exercised in full, total proceeds to the Company resulting from this transaction will equal approximately $8 million. The additional funds raised will be used to further fund core diagnostic and therapeutic programs, as well as execute -various business development opportunities. The closing of this transaction is subject to the satisfaction of customary closing conditions and is expected to occur on or before October 1, 2013. GVC Capital LLC acted as exclusive placement agent, and Zacks & Company acted as financial advisor.